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Abstract We have purified Gas6 as a growth-potentiating 
factor for vascular smooth muscle cells (VSMCs) (Nakano, T. et 
al. (1995) J. Biol. Cbem. 270, 570247053. However, specific 
production of Gas6 in growth-arrested cells raises an intriguing 
question as to the physiological function of Gasd In this study, 
we found that serum-starved VSMCs secreted some survival 
factors and depletion of the factors induced cell death of 
VSMCs. Finally, we demonstrated that cell death was prevented 
by the addition of Gas6, suggesting that one of the major 
biological activity of Gas6 is protection of growth-arrested 
VSMCs from death. 
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1. Introduction 
In a previous paper, we demonstrated the isolation of a 
novel vascular smooth muscle cell (VSMC)-derived growth- 
potentiating factor from the culture medium of VSMCs [l]. 
The factor specifically potentiates proliferation of VSMCs 
stimulated with G-protein-coupled substances, such as throm- 
bin, angiotensin II or lysophosphatidic acid, and has a speci- 
fic, high affinity binding site on VSMC membranes [l]. Thus, 
it is suggested that the factor plays an important role in the 
proliferation of VSMCs induced by these growth-stimulating 
substances. Structural analysis of the growth-potentiating fac- 
tor revealed that the factor was a y-carboxyglutamic acid 
(Gla)-containing protein encoded by a growth arrest-specific 
gene, gas6 [1,2]. Therefore, the growth-potentiating factor is 
referred to as Gad. The gas6 gene was cloned as one of the 
growth arrest-specific genes isolated by subtractive hybridiza- 
tion on the basis of preferential expression in the Go phase of 
the cell cycle [3]. Expression of gad is up-regulated when cells 
are growth-arrested by serum deprivation and down-regulated 
upon mitogenic stimulation [2,3]. Recently, it has been re- 
ported that Gas6 is a ligand for a receptor tyrosine kinase 
Ax1 and its relative Sky [4-61. Their genes were cloned on 
the basis of transforming activity or homology with other 
tyrosine kinases [7-lo]. From these findings, it is expected 
that stimulation of cells with gas6 may activate Ax1 or Sky, 
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dehydrogenase 
resulting in phosphorylation of tyrosine residues of Ax1 and 
Sky, or other substrates, which may enhance the mitogenic 
response of cells. 
However, there is an inconsistency in understanding the 
major biological function of Gas6 to be the growth-potenta- 
tion of cells, since the production of Gas6 by cells is specifi- 
cally induced during the growth-arrested state, when cell pro- 
liferation is not necessary [2,3]. In this paper, we report that 
Gas6 prevents growth arrest-induced cell death of VSMCs, 
demonstrating that prevention of cell death may be one of 
the important biological roles of Gas6. 
2. Materials and methods 
2.1. Materials 
Rat Gas6 was purified from the culture medium of CHO cells 
transfected with rat Gas6 expression plasmid as described elsewhere 
[l]. Platelet-derived growth factor (PDGF) and basic fibroblast 
growth factor (bFGF) were purchased from Boehringer Mannheim, 
and heparin-binding EGF-like growth factor (HB-EGF) were from 
R&D Systems, Inc. Vitamin K2 was purchased from Sigma. 
2.2. Culture of VSMCs 
VSMCs isolated from thoracic aortas of male adult rats were cul- 
tured in Dulbecco’s modified Eagle’s medium (DMEM) containing 
10% fetal calf serum. Cells at passage 6-10 were used for experiments. 
2.3. Induction of cell death 
Culture medium of confluent VSMCs in 24-well plates was replaced 
with DMEM containing 0.05% bovine serum albumin (BSA) and the 
cells were cultured for 2 days. To induce cell death, the culture me- 
dium was replaced again with fresh DMEM containing 0.05% BSA. 
2.4. Monitoring of cell death 
Cell survival was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium bromide (MTT) assay, which measures mito- 
chondrial dehydrogenase activity [ll]. VSMCs were cultured for 4 h 
with 0.5 mg/ml MTT. Viable cells with active mitochondria produce 
dark blue formazan reaction product, whereas dead cells remain un- 
colored. The formazan product was dissolved with 10% SDS contain- 
ing 5 mM HCl and quantified by measuring the absorbance at 570 
nm. Lactate dehydrogenase (LDH) released into the culture medium 
was measured using an LDH assay kit (Kyokuto, Japan). Survival is 
expressed as the value at the second medium change to be 100%. 
LDH release was expressed as LDH released from intact VSMCs 
with 0.1% Triton X-100 to be 100%. 
3. Results and discussion 
Many types of cells in culture have been shown to die by 
deprivation of essential growth factors [12]. These include 
vascular endothelial cells deprived of FGF [13], mouse em- 
bryo cells after removal of epidermal growth factor [14], rat 
pheochromocytoma PC12 cell line and sympathetic neurons 
deprived of nerve growth factor [ 151, hormone-dependent cells 
of the breast or prostate deprived of steroids [16,17] and glial 
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Fig. 1. Growth arrest-indu~ celi death of VSMCs. Confluent 
VSMCs were cultured for 2 days in DMEM containing 0.05% BSA, 
and at day 0, the medium was replaced again with fresh DMEM 
containing 0.05% BSA (open circles) or not replaced (closed circles). 
Survival of VSMCs (A) and release of LDH (B) were assayed as de- 
scribed in section 2. Error bars represent SD. (n=3). 
cells deprived of PDGF [18]. Therefore, serum-free cuhure 
medium without growth factors appears to be a cell death- 
favoring factor. However, as reported by Leszczynski et al. 
[19], normal VSMCs did not die for 5 days in serum-free 
medium (Fig. IA). We then postulated that some autocrine 
survival factors might be released from VSMCs and prevent 
cell death. To confirm this hypothesis, we replaced the culture 
medium again with serum-free medium 2 days after the first 
medium change. In this condition, the cells started to die 2 
days after the second medium change when monitored with 
the MTT assay (Fig. IA). In parallel with the decrease of cell 
survival monitored with the MTT assay, release of LDH, one 
of the indicators of cell damage, was increased (Fig. IB). 
These results demonstrated that some survival factors released 
from VSMCs during the first 2 days of serum starvation pre- 
vent cell death of VSMCs induced by serum-free, growth-ar- 
rested conditions. 
Fig. 2. Prevention of cell death of VSMCs by Gas6. Confluent 
VSMCs were cultured for 2 days in DMEM containing 0.05% BSA. 
Then, the medium was replaced again with fresh DMEM containing 
0.05% BSA, and the cells were cultured in the presence or absence 
(NA) of various concentrations of Gas6 for a further 3 days. Survi- 
val of VSMCs was assayed as described in section 2. Error bars re- 
present SD. (n=3). 
It was reported that in serum-free, growth-arrested condi- 
tions, production of Gas6 was dramati~lly enhanced [2,3]. 
We consequently h~othesized that Gas6 might be one of 
the survival factors and examined the effect of Gas6 on the 
growth arrest-induced cell death of VSMCs. As shown in Fig. 
2, Gas6 dose dependently prevented growth arrest-induced 
cell death when added to VSMCs after the second medium 
change. This result indicates that Gas6 exerts an activity of 
preventing cell death of VSMCs. 
We have reported that VSMCs produce active, Gla-con- 
taming Gas6 during the first 2 days of Serb-starvation [I]. 
However, after the second medium change with serum-free 
medium, VSMCs mainly produce inactive Gas6 without Gla 
residues due to the depletion of vitamin K in the medium 
(Nakano et al., unpublished results). We then added vitamin 
K to the medium after the second medium change in order to 
examine the effect of vitamin IS on the cell death of VSMCs. 
As a result, the addition of vitamin K also prevented cell 
death of VSMCs (Fig. 3). 
The results described so far strongly suggest that Gas6 is a 
survival factor for growth arrest-induced cell death of VSMCs 
and vitamin K-dependent ~-carboxylation of Gas6 is essen- 
tially indispensable for its activity. However, it has been re- 
ported that VSMC releases other growth factors such as 
PDGF and HB-EGF [ZO], which are also candidates for the 
survival factors of VSMC. Indeed, as shown in Fig. 3, PDGF- 
BB, HB-EGF, and bFGF also prevented growth arrest-in- 
duced cell death of VSMCs. However, expression of these 
growth factors is up-regulated when cells are stimulated 
with mitogenic substances, and their expression is scarcely 
detected when cells are growth-arrested [20], Therefore, these 
growth factors do not appear to be candidates for the survival 
factor of growth arrest-induced cell death. Moreover, these 
-I 
Fig. 3. Prevention of cell death of VSMC by vitamin K and other 
growth factors. Confluent VSMCs were cultured for 2 days in 
DMEM containing 0.05% BSA. The medium was then replaced 
again with fresh DMEM containing 0.05% BSA, and the cells were 
cultured in the presence or absence (NA) of vitamin K, Gas6, 
PDGF-BB, HB-EGF or bFGF for a further 3 days. Survival of 
VSMCs was assayed as described in section 2. Error bars represent 
S.D. (n=3). 
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growth factors not only prevent cell death but also induce 
proliferation of VSMC [21,22], whereas Gas6 does not induce 
cell proliferation by itself [l]. This specific characteristic of 
Gas6 may be preferable to maintaining viability of quiescent 
cells. 
[4] Varnum, B.C., Young, C., Elliott, G., Garcia, A., Bartley, T.D., 
Fridell, Y.-W., Hunt, R.W., Trail, G., Clogston, C., Toso, R.J., 
Yanagihara, D., Bennett, L., Sylber, M., Merewether, L.A., 
Tseng, A., Escobar, E., Liu, E.T. and Yamane, H.K. (1995) 
Nature 373, 623-626. 
Thus, we concluded that one of the major biological activ- 
ities of Gas6 is to protect VSMC from growth arrest-induced 
cell death. It is quite reasonable that a role of a product of 
growth arrest-specific gene is the prevention of growth arrest- 
induced cell death. However, Gas6 alone may not be a survi- 
val factor for the cell death of VSMC, since inhibition of Gas6 
activity by anti-Gas6 antibody or inhibition of vitamin K- 
dependent y-carboxylation of Gas6 by warfarin, an inhibitor 
of vitamin K, failed to induce cell death of VSMC when the 
antibody and warfarin were added instead of the second me- 
dium change (data not shown). Furthermore, the concentra- 
tion of Gas6 in the culture medium of growth-arrested 
VSMCs was less than 2 nM (data not shown), which is not 
enough to prevent cell death (Fig. 2). Therefore, VSMCs may 
also secrete other survival factors to prevent cell death. 
[5] Stitt, T.N., Corm, G., Gore, M., Lai, C., Bruno, J., Radziejewski, 
C., Mattsson, K., Fisher, J., Gies, D.R., Jones, P.F., Masiakows- 
ki, P., Ryan, T.E., Tobkes, N.J., Chen, D.H., DiStefano, P.S., 
Long. G.L.. Basilica. C.. Goldfarb. M.P.. Lemke. G.. Glass. D.J. 
andYancopoulos, G.D.’ (1995) Cell 80, 661-670: ’ 
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Potentiation of VSMC proliferation [l] and prevention of 
cell death of VSMCs described in this study are the biological 
activities of Gas6 demonstrated so far. It is interesting to note 
that both Gas6 and its receptor Ax1 are widely expressed in 
various tissues [1,7,8], whereas another type, Sky, is restricted 
to the brain [9,10]. Thus, Gas6 may have some distinctive 
physiological roles in respective tissues. We are now conduct- 
ing further studies to clarify this problem. 
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